Pyridam Farma’s loss worsened to IDR 214.2 billion in 9M 2024
04 Nov 2024 06:04
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, booked net loss of IDR 214.2 billion in the first nine months (9M) 2024.
04 Nov 2024 06:04
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, booked net loss of IDR 214.2 billion in the first nine months (9M) 2024.
19 Jul 2024 09:51
One of the subsidiaries of PT Pyridam Farma Tbk (PYFA), namely Pyfa Health Singapore Pte. Ltd. (Pyfa Singapore), has obtained a credit facility worth US$ 15 million or around IDR 242.6 billion.
12 Jun 2024 09:25
PYFA Australia Pty Ltd (PAPL), an entity under PT Pyridam Farma Tbk (PYFA), has secured extra capital of USD 99.57 million or equal to approximately IDR 1.07 trillion.
26 Jan 2024 09:26
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company under Rejuve Global Investment, will issue its Shelf-Registration Bonds I of PYFA Phase III Year 2024, with a total principal of IDR 400 billion.
09 Jan 2024 09:42
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company operating since 1997, has managed to obtained approval during the Extraordinary General Meeting of Shareholders regarding the rights issue.
22 Dec 2023 09:36
PT Pyridam Farma Tbk (PYFA) has signed a Scheme Implementation Deed (SID) regarding the plan of one of its subsidiaries to take over shares of Probiotec, an Australia-based pharmaceutical company.
28 Nov 2023 21:01
PT Pyridam Farma Tbk (PYFA) will issue 16 billion new shares by providing Pre-emptive Rights (HMETD) or rights issue.
15 Sep 2023 09:57
PT Pyridam Farma Tbk (PYFA) once again offers Shelf-Registration Bonds I of PYFA Phase II Year 2023 with a total principal of IDR 400 billion.
29 Aug 2023 20:40
PT Pyridam Farma Tbk (PYFA) will issue Shelf Registration Bonds I Phase II Year 2023, with a principal amount of IDR 400 billion.